The benefits of antioxidant micronutrients in slowing progression to advanced stages of age-related macular degeneration ( AMD ) was supported by the 4/day tablet form investigated in the Age-related Eye Disease Study 1 ( AREDS1 ) and the 2/day softgel form in the Age-related Eye Disease Study 2 ( AREDS2 ) .